EDWARDS LIFESCIENCES CORPORATION Funds and ETFs Edwards Lifesciences Corporation
Equities
EW
US28176E1082
Advanced Medical Equipment & Technology
|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 86.66 USD | +1.85% |
|
+1.76% | +13.52% |
ETFs positioned on Edwards Lifesciences Corporation
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 2.46% | 0 M€ | +1.60% | - | |
| 2.34% | 0 M€ | +5.54% | - | |
| 2.13% | 0 M€ | 0.00% | - | |
| 1.17% | 0 M€ | -0.73% | - | |
| 1.17% | 0 M€ | -0.30% | - | |
| 1.17% | 0 M€ | +3.43% | - | |
| 1.11% | 0 M€ | -5.02% | ||
| 1.06% | 0 M€ | +8.89% | ||
| 0.97% | 1 M€ | +2.21% | - | |
| 0.94% | 4,592 M€ | +11.18% | ||
| 0.89% | 0 M€ | -.--% | ||
| 0.73% | 9 M€ | -.--% | - | |
| 0.52% | 1 M€ | +16.32% | ||
| 0.46% | 2 M€ | +20.44% | - | |
| 0.44% | 5 M€ | -72.95% | - | |
| 0.42% | 469 M€ | -2.05% | - | |
| 0.42% | 3,859 M€ | +18.82% | - | |
| 0.36% | 0 M€ | -.--% | ||
| 0.36% | 0 M€ | +12.42% | ||
| 0.34% | 36 M€ | +22.19% | ||
| 0.33% | 0 M€ | +9.11% | ||
| 0.33% | 0 M€ | +3.13% | - | |
| 0.30% | 0 M€ | +8.02% | ||
| 0.30% | 1,448 M€ | -.--% | - | |
| 0.30% | 219 M€ | +17.17% | - | |
| 0.25% | 0 M€ | -.--% | - | |
| 0.24% | 0 M€ | +8.31% | - | |
| 0.24% | 0 M€ | +11.06% | ||
| 0.24% | 330 M€ | -.--% | - | |
| 0.23% | 2 M€ | +14.69% | - | |
| 0.23% | 0 M€ | +8.05% | ||
| 0.23% | 0 M€ | +4.95% | - | |
| 0.21% | 276 M€ | +11.40% | - |
Edwards Lifesciences Corporation specializes in designing, manufacturing and marketing medical systems and devices for treating cardiovascular diseases. Net sales break down by family of products as follows:
- heart valves and surgery products (67.9%);
- hemodynamic monitoring systems (15.5%);
- other (16.6%): balloon catheters, artificial implants, etc.
Net sales are distributed geographically as follows: the United States (58.4%), Europe (22.2%), Japan (7.6%) and other (11.8%).
Calendar
2024-07-24
- Q2 2024 Earnings Release (Projected)
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
B+
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
31
Last Close Price
85.09
USD
Average target price
95.27
USD
Spread / Average Target
+11.97%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +13.52% | 51.28B | |
| +8.56% | 219B | |
| +7.93% | 185B | |
| +14.23% | 135B | |
| +27.44% | 107B | |
| +4.88% | 51.01B | |
| +3.79% | 41.85B | |
| +6.20% | 37.02B | |
| +25.00% | 31.27B | |
| +17.52% | 23.66B |
- Stock Market
- Equities
- EW Stock
- Funds and ETFs Edwards Lifesciences Corporation